CMIC’s China Office was established in 2007 in Beijing, China to provide full operational services in the execution of clinical trials under the Pharmaceutical Value Creator (PVC) model. With more than 5 years’ experience in the Greater China region and beyond for projects of global and local scales, we understand the country’s biopharmaceutical and healthcare markets.
Our combination of industry experience and expertise across a broad spectrum of therapeutic areas and phases can help you accelerate clinical and commercial success to deliver better medicines, sooner.
It is well known that the Chinese regulations are fast changing, allowing for faster clinical trials, but with changes come challenges. In China, CMIC ensures that sites can keep up with changing regulations, carefully selecting experienced sites from our network, and supporting understaffed sites with on-site CRCs.
Regulatory consultation and dossier submission to health authorities (HA) and ethics committees (EC)
Clinical monitoring and site management
Full Biometrics support and Clinical Study Report (CSR) writing
Pharmacovigilance and medical monitoring
Quality assurance and quality compliance services
Facility Contact Information
Twin Towers East Building, Unit 1702, B-12 Jianguomenwai Avenue, Chaoyang District, Beijing, 100022, China
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.